Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.
A total of 108 college women with acute urinary tract infections were treated for 10 days with either 500 mg of cefprozil (BMY-28100-03-800) once a day (n = 72) or 250 mg of cefaclor three times a day (n = 36). Clinical and bacterial cure rates at 1 week posttherapy were 94 and 93%, respectively, for the cefprozil group and 94 and 94%, respectively, for the cefaclor group (P, not significant). Both cefprozil and cefaclor were safe and effective.
Iravani
A
A
Pediatric Nephrology, College of Medicine, University of Florida, Gainesville 32610-0296.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D002433:Cefaclor / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D005260:Female; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000302:isolation & purification; D006801:Humans; D014552:Urinary Tract Infections / Q000188:drug therapy*; D000097670:Cefprozil
D002433:Cefaclor; D002511:Cephalosporins; D000097670:Cefprozil